Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 24.02 CNY | +2.69% |
|
+3.85% | -9.32% |
| 09-23 | Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products | MT |
| 09-14 | Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5% | MT |
| Market Cap | 58.95B 8.79B 7.74B 7.33B 6.62B 12.48B 843B 12.64B 87.73B 33.76B 431B 33B 32.28B 1,381B | P/E 2026 * |
16.6x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 71.82B 10.71B 9.43B 8.93B 8.06B 15.2B 1,027B 15.4B 107B 41.13B 525B 40.2B 39.33B 1,683B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 1.67x |
| Free-Float |
62.66% | Yield 2026 * |
1.87% | Yield 2027 * | 2.13% |
| 1 day | +2.69% | ||
| 1 week | +3.85% | ||
| Current month | +7.42% | ||
| 1 month | +5.03% | ||
| 3 months | +5.68% | ||
| 6 months | -8.08% | ||
| Current year | -9.32% |
| 1 week | 22.79 |  | 24.1 |
| 1 month | 21.5 | | 24.1 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 30.09 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 58.95 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 24/06/2025 |
Zhi Huang
DFI | Director of Finance/CFO | - | 02/04/2026 |
Wen Jie Zhang
PSD | President | 59 | 01/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 01/04/1994 |
Yi Liu
BRD | Director/Board Member | 50 | 02/12/2025 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 30/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/30/25 A | Sell | Chief Executive Officer | 87,448 | 0.0041% | ||
| 5/30/25 A | Sell | Executive/Senior Manager | 31,790 | 0.0015% | ||
| 5/30/25 A | Sell | Chairman | 63,614 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.69% | +3.85% | -18.19% | -16.01% | 8.55B | |
| -1.48% | +1.87% | +53.67% | +117.82% | 1,056B | |
| -0.65% | -1.10% | +43.57% | +71.58% | 645B | |
| -0.09% | -0.71% | +13.67% | +77.54% | 465B | |
| -2.27% | -1.08% | +74.53% | +42.84% | 368B | |
| -0.06% | -3.88% | +34.32% | +40.74% | 335B | |
| -0.79% | +2.01% | +19.82% | +28.48% | 275B | |
| -1.19% | -1.21% | +9.82% | +12.15% | 255B | |
| -0.55% | +4.10% | +49.80% | +58.74% | 229B | |
| -0.79% | -0.69% | +35.42% | +102.86% | 188B | |
| Average | -0.46% | +0.50% | +31.64% | +53.67% | 382.43B | |
| Weighted average by Cap. | -0.92% | +0.31% | +40.77% | +73.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.53B 6.34B 5.58B 5.29B 4.78B 9B 608B 9.12B 63.29B 24.35B 311B 23.81B 23.29B 996B | 43.6B 6.5B 5.72B 5.42B 4.9B 9.23B 623B 9.35B 64.89B 24.97B 319B 24.41B 23.88B 1,022B |
| Net income | 3.84B 573M 504M 478M 431M 813M 54.9B 823M 5.72B 2.2B 28.07B 2.15B 2.1B 89.99B | 4.39B 654M 576M 546M 493M 929M 62.74B 941M 6.53B 2.51B 32.07B 2.46B 2.4B 103B |
| Net Debt | 12.86B 1.92B 1.69B 1.6B 1.44B 2.72B 184B 2.76B 19.14B 7.37B 94B 7.2B 7.04B 301B | 14.06B 2.1B 1.85B 1.75B 1.58B 2.98B 201B 3.02B 20.93B 8.05B 103B 7.87B 7.7B 330B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥24.02 | +2.69% | 36,991,830 |
| 29/09/26 | CN¥23.39 | +0.65% | 29,058,014 |
| 28/09/26 | CN¥23.24 | +1.75% | 24,656,255 |
| 24/09/26 | CN¥22.84 | -1.25% | 15,937,032 |
| 23/09/26 | CN¥23.13 | 0.00% | 18,292,541 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Select your edition
All financial news and data tailored to specific country editions
